Citigroup’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,284,070
| Closed | -$52.5M | – | 4988 |
|
|
2024
Q2 | $52.5M | Sell |
1,284,070
-611,060
| -32% | -$25M | 0.03% | 351 |
|
|
2024
Q1 | $80.1M | Buy |
1,895,130
+1,383,064
| +270% | +$58.5M | 0.05% | 225 |
|
|
2023
Q4 | $21.7M | Buy |
512,066
+428,280
| +511% | +$18.2M | 0.02% | 561 |
|
|
2023
Q3 | $1.83M | Buy |
83,786
+15,507
| +23% | +$339K | ﹤0.01% | 1527 |
|
|
2023
Q2 | $2.17M | Sell |
68,279
-100,510
| -60% | -$3.2M | ﹤0.01% | 1633 |
|
|
2023
Q1 | $4.12M | Buy |
168,789
+62,826
| +59% | +$1.53M | ﹤0.01% | 1200 |
|
|
2022
Q4 | $3.34M | Sell |
105,963
-33,638
| -24% | -$1.06M | ﹤0.01% | 1248 |
|
|
2022
Q3 | $3.95M | Buy |
139,601
+60,738
| +77% | +$1.72M | ﹤0.01% | 1223 |
|
|
2022
Q2 | $2.09M | Buy |
78,863
+58,159
| +281% | +$1.54M | ﹤0.01% | 1547 |
|
|
2022
Q1 | $725K | Sell |
20,704
-101,345
| -83% | -$3.55M | ﹤0.01% | 2593 |
|
|
2021
Q4 | $3.96M | Sell |
122,049
-74,444
| -38% | -$2.41M | ﹤0.01% | 1436 |
|
|
2021
Q3 | $5.8M | Buy |
196,493
+131,492
| +202% | +$3.88M | ﹤0.01% | 1218 |
|
|
2021
Q2 | $1.67M | Sell |
65,001
-39,272
| -38% | -$1.01M | ﹤0.01% | 2233 |
|
|
2021
Q1 | $1.43M | Buy |
104,273
+12,530
| +14% | +$172K | ﹤0.01% | 2138 |
|
|
2020
Q4 | $1.52M | Buy |
+91,743
| New | +$1.52M | ﹤0.01% | 1873 |
|